Nov 8, 2024, 19:29
Single-cell RNA sequencing shows relevance for drug target selection
A recent paper by Marios Georgakis, Emmy Noether Research Group Leader and Clinician at LMU Munich, on X:
, EMBO post-doctoral fellow in the Pritchard Lab at Stanford University, was mentioned by“Beyond genomics, single-cell RNA sequencing also shows relevance for drug target selection.
Targets with
- high expression in disease-relevant cell types or
- cell-type overexpression in disease patients,
are more likely to proceed in clinical development.”
“Estimating the impact of single-cell RNA sequencing of human tissues on drug target validation”
Authors:
, , , , , , , ,More posts about single-cell RNA sequencing.
Emma Dann is a computational biologist with expertise in analyzing single-cell genomics data. She is currently an EMBO postdoctoral fellow at the Pritchard Lab at Stanford University and the Gladstone Institutes, as well as a visiting fellow in the Marson Lab at the Gladstone Institutes.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 13:44
Nov 12, 2024, 13:24
Nov 12, 2024, 13:21
Nov 12, 2024, 13:07
Nov 12, 2024, 12:57